{"id":"homologous-boost-schedule","safety":{"commonSideEffects":[{"rate":null,"effect":"Injection site pain or swelling"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Myalgia"},{"rate":null,"effect":"Fever"}]},"_chembl":{"chemblId":"CHEMBL4297922","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Homologous boost schedules involve repeated doses of an identical vaccine to strengthen and broaden the adaptive immune response. This approach is commonly used in infectious disease vaccination to increase antibody titers, expand T-cell populations, and improve immunological memory. The timing and number of boosts are designed to maximize protective immunity.","oneSentence":"A homologous boost vaccination schedule that enhances immune response by administering the same vaccine formulation multiple times at optimized intervals.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:22:37.261Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention (homologous booster schedule)"}]},"trialDetails":[{"nctId":"NCT05054621","phase":"PHASE2","title":"Immunogenicity of COVID-19 Vaccine on Heterologous Schedule","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-09-15","conditions":"Covid-19, Vaccine, Immunogenicity","enrollment":100},{"nctId":"NCT05079633","phase":"PHASE4","title":"A Heterologous Prime-boost Study to Evaluate Immunogenicity and Safety of mRNA-1273 With MVC-COV1901 in Adults","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2021-09-30","conditions":"Covid19 Vaccine","enrollment":220},{"nctId":"NCT05668065","phase":"PHASE3","title":"Immunogenicity of Heterologous Versus Homologous Prime Boost Schedule With mRNA and Inactivated COVID-19 Vaccines","status":"COMPLETED","sponsor":"Institut Pasteur de Tunis","startDate":"2021-11-22","conditions":"COVID-19","enrollment":199},{"nctId":"NCT05087368","phase":"PHASE2","title":"Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)","status":"UNKNOWN","sponsor":"D'Or Institute for Research and Education","startDate":"2021-12-01","conditions":"Covid19","enrollment":520},{"nctId":"NCT03589807","phase":"PHASE2","title":"2013/2017 H7N9 Prime-Boost Interval","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-08-21","conditions":"Avian Influenza, Influenza Immunisation","enrollment":180},{"nctId":"NCT02325050","phase":"PHASE1","title":"A Safety and Immunogenicity Study of Heterologous and Homologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2015-01-08","conditions":"Healthy","enrollment":164},{"nctId":"NCT00219362","phase":"PHASE2","title":"Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients","status":"COMPLETED","sponsor":"Objectif Recherche Vaccins SIDA","startDate":"2004-04","conditions":"HIV Infection","enrollment":65}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Homologous boost schedule","genericName":"Homologous boost schedule","companyName":"National Taiwan University Hospital","companyId":"national-taiwan-university-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"A homologous boost vaccination schedule that enhances immune response by administering the same vaccine formulation multiple times at optimized intervals. Used for COVID-19 prevention (homologous booster schedule).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}